In The News Posted October 8, 2021 Share Posted October 8, 2021 BALTIMORE, Oct. 8, 2021 /PRNewswire/ -- Elixirgen Therapeutics, Inc., a Baltimore-based biotechnology company focused on the discovery and development of therapies for genetic diseases and vaccines, today announced it has entered into an exclusive licensing agreement with a global...View the full article Quote Link to comment Share on other sites More sharing options...
Recommended Posts